Abstract
Cardiotoxicity associated with the use of chemotherapy has been largely corroborated through multiple clinical trials. In Costa Rica, the development of Cardio-oncologic Units has begun recently in various medical centers with the purpose of achieving an early detection of the deleterious cardiovascular effect associated with different chemotherapeutics. This review consists of a summary of the clinical manifestations related to the use of anthracyclines available in the Costa Rican public health system.
Comments
Downloads
Download data is not yet available.